The antimalarial activity of sixteen ent-kaurenes was assayed on male albino mice infected with Plasmodium berghei. , 15-hydroxy-ent-kaur-16-en-19-oic acid, 15-acetoxy-ent-kaur-16-en-19-oic acid, and ent-kaur-9(11) 16-en-19-oic acid, natural kaurenes isolated from two species of Espelletiinae, were modified by semisynthesis to obtain methyl esters, glucopyranosyl esters, epoxides, 17-hydroxy, and isokaurenes (compounds with a 15,16-double bond). The kaurenes were first submitted to an in vitro test to measure their capacity to inhibit the formation of -hematin. Compared with chloroquine (95.7%), the best effect was shown by 16,17-epoxy-ent-kauran-19-oic acid α-D-glucopyranosyl ester (2a), which produced 92.6% inhibition. Three other kaurenes showed good inhibition levels : ent-kaur-16-en-19-oic acid (1a, 73.5%), 17-hydroxy-ent-kaur-15-en-19-oic acid methyl ester (3b, 76.5%), and 15-oxo-16,17-epoxy-ent-kaur-16-en-19-oic acid -D-glucopyranosyl ester (4b,76.1%). These four compounds were assayed in a four day suppressive test in vivo (Peters´ test) using chloroquine as a positive control. Two hours after infection the mice received the first treatment and then every 24 hours during four consecutive days. Blood smears from the tails were prepared on the fourth day and parasitemia was determined microscopically. Survivals were followed up to the 30 th day post-infection, Once again compound 2a performed best, showing 4.5% of parasitemia on the fourth day post-infection (chloroquine 0.2%) and a survival time of 25.5 days (chloroquine 29.5 days; 1a 18.8 days, 4b 12.7 days and 3b 10.3 days). A comparative examination of the effect of all compounds on the in vitro test permitted the inference that the presence of a C-19 carboxylic moiety was a requirement for the antimalarial activity and that a 16,17 epoxy group enhanced such activity.
Malaria is an infectious disease caused by protozoan parasites of the genus Plasmodium [1a] . It has afflicted humans since ancient times affecting each year, in tropical areas of the world, over 300 million people and it is fatal to more than one million every year, mainly children under five years old. Four species of Plasmodium are infectious to humans and are transmitted through the bite of an infected female mosquito of the Anopheles genus. Nowadays, for either the prevention or treatment of malaria several synthetic compounds are used, like 4-aminoquinolines, 8-aminoquinolines, arylamino-alcohols, artemisinins, antifolates, antibiotics and inhibitors of the respiratory chain [1b] . The need for such a wide arsenal of drugs against malaria has arisen because the Plasmodium parasites have developed resistance, which consists of a mechanism to expel the drugs from their cytoplasm. Therefore, the search for new substances capable of controlling malaria has become a global need [1c] .
Kaurenes are diterpenes with a rigid tetracyclic skeleton. Entkaurenic acid has been reported to have moderate anti-microbial activity and to be active against Trypanosoma cruzi. It was also shown to have molluscicidal properties, but one of the most interesting biological properties of kaurenes is their moderate in vitro activity against several cancer cell lines [1d] . To assay their possible antimalarial activity sixteen kaurenes were tested on male mice infected with Plasmodium berghei, a rodent parasite. The tested kaurenes ( Figure 1) were : ent-kaur-16-en-19-oic acid (1a), ent-kaur-16-en-19- 15-oxo-16,17-epoxy-ent-kauran-19-oic acid -D-glucopyranosyl ester (4b), ent-kaur-16-en-19-al (5), ent-kaur-9(11)16-dien-19-oic acid (6a), 9,11-16,17-diepoxy-entkauran-19-oic acid (6b) , and 15,16-epoxy-17-hydroxy-ent-kauran-19-oic acid-methyl ester (7). -kaur-16-en-19-oic acid (kaurenic acid, 1a) and ent-kaur-16-en-19-al (5) were obtained from Espeletia semiglobulata, and 15-hydroxy-ent-kaur- 16-en-19-oic acid (1c), ent-kaur-(9,11)16-dien-19-oic acid (6a) and 15-O-acetyl-ent-kaur-16-en-19-oic acid from E. schultzii. Both are Venezuelan species of the Espelletiinae subtribe (Compositae) [2a] . The other kaurenes were produced by semisynthesis from the above mentioned natural compounds. Isokaurenic acid (ent-kaur-15-en-19-oic acid) was obtained by isomerization of kaurenic acid [2b]; treatment with diazomethane yielded the methyl esters; and reaction with dimethyl oxirane yielded the epoxy derivatives. Oxidation of 1c with Sarett's reagent rendered 15-oxo-ent-kaur-16-en-19-oic acid. The glucopyranosyl esters were obtained using the technique described by Visbal et al [2c] .
Ent
To assay the possible antimalarial activity of the kaurenes, the inhibition of -hematin synthesis in vitro was tested according to Baelman's procedure [2d] , using chloroquine as a positive control. Results are presented in Table 1 . In the first column the kaurenes are identified according to the numbering system used in Figure 1 . In the second column, the inhibition of β-hematin formation (% IβHF) obtained by each kaurene is presented. Compared with chloroquine (95.7%) the best inhibitory effect was shown by 16,17-epoxy-ent-kauran-19-oic acid -D-glucopyranosyl ester (2a), which produced 92.6% inhibition. Three other kaurenes attained more than 70% inhibition: ent-kaur- 16-en-19-oic acid (1a, 73.5%), 17-hydroxy-ent-kaur-15-en-19-oic acid methyl ester (3b, 76.5%) , and 15-oxo-16,17-epoxy-ent-kauran-19-oic acid -D-glucopyranosyl ester (4b,76.1%). On the other hand, two compounds performed very poorly: 15-hydroxy-ent-kaur-16-en-19-oic acid (1c, 8.1%), and ent-kaur- 16-en-19-al (5, 6.4%) . Some conclusions could be drawn from this experiment. The first would be that the presence of a carboxylic acid moiety at C-19 is a requirement for good antimalarial activity; if the carboxyl group is replaced by an aldehyde group the capacity to inhibit -hematin synthesis disappears. On the other hand, the presence of a hydroxyl at C-15 seems to be negative, but at C-17 to be positive, even more so if there is an epoxy group at C16-C17. The results are expressed as the mean ± SEM. n=4
Only those kaurenes that showed inhibition of -hematin synthesis in vitro higher than 70% were submitted for in vivo evaluations. Therefore, compounds 2a, 1a, 3b, and 4b were assayed by the fourday suppressive Peters´ test [2e] using chloroquine as the positive control. Mice were infected intraperitoneally with parasitized red The results are expressed as the mean ± SEM. %P: percentage of parasitemia at 4th day post-infection; SDPI: survival days post-infection. ***p<0.001; **p<0.01 and † p>0.05 compared with non-treated infected mice (saline solution). n=5. blood cells. Two hours after infection, animals received by ip the first treatment of 25 mg/kg of an individual kaurene, which was repeated every 24 hours for four consecutive days. Parasitemia and survivals were determined. Results are shown in Table 2 .
Peters´ test indicated that 16,17-epoxy-ent-kauran-19-oic acid -Dglucopyranosyl ester (2a) showed the best antimalarial properties among the group of tested kaurenes. Indeed, this compound was able to decrease the parasitemia levels and increased the survival time post-infection in the most significant manner, showing the same survival rates as the control, chloroquine. Thus, we suggest that this compound might be suitable for consideration for further studies in malaria research for inhibition of the -hematin synthesis mechanism. 
Experimental

16,17-Epoxy-kauran-19-oic acid -D-glucopyranosyl ester (2a):
Ent-kaur-16-en-19-oic acid -D-glucopyranosyl ester (1b, 100 mg, 0.215 mmol) was dissolved in acetone and treated overnight at room temperature with a dimethyloxirane solution in acetone, as described by Adams et al. [4a] 
Ent-kaur-15-en-19-oic acid methyl ester (3a):
Kaurenic acid (1a) was methylated with diazomethane, dissolved in dry CH 2 Cl 2 and treated with 10 drops of trifluoroacetic acid under reflux, as described by Rojas et al. [4b] . Under these conditions the methyl ester of 1a isomerized to yield 66.6% of iso-kaurenic acid (3a), which was separated from its isomer on a column of silica gel impregnated with 20% AgNO 3 . Compound 3a was identical to that reported by Rojas et al. [4b] .
17-O-Acetyl-ent-kaur-15-en-19-oic acid methyl ester (3c):
One g of kaurenic acid methyl ester (3.17 mmol) was dissolved in 5 mL dry benzene and refluxed with 80 mL of glacial acetic acid and 3.0 g (0.67 mmol) of lead tetra-acetate under an argon atmosphere. The course of the reaction was followed by TLC using n-hexane: EtOAc (3:1). After 30 min, H 2 O was added and the mixture shaken with CHCl 3 . The organic layer was dried over dry Na 2 SO 4 and the CHCl 3 17-Hydroxy-ent-kaur-15-en-19-oic acid methyl ester (3b): Three hundred mg (0.8 mmol) of 3c was dissolved in dry MeOH and treated overnight at room temp with anhydrous NH 3 . The methanolic soln was then concentrated to yield 245 mg of 3b, identical to the compound described by Rojas et al. [4b] .
15-Oxo-ent-kaur-16-1n-19-oic acid -D-glucopyranosyl ester (4a):One gmmol)of-hydroxy-ent-kaur-16-en-19-oic acid (1c) was dissolved in 20 mL of pyridine and treated overnight with 1.25 g (1.25 mmol) of CrO 3 -pyridine complex (Sarett´s reagent). The following day, 100 mL of H 2 O was added to the reaction mixture and the oxidation product was extracted with Et 2 O. The Et 2 O soln was concentrated to dryness and the residue submitted to flash chromatography over silica gel. Elution with n-hexane-diethyl ether yielded 0.83 g of 15-oxo-ent-kaur-16-en-19-oic acid, identical to the compound reported by Ruiz et al. [4c] . The glucopyranosyl ester (4a) was obtained as described previously for 1b, 1d, and 1e; it was crystallized from MeOH. 15-Oxo-ent-kaur-16-en-19-oic acid (480 mg, 1.0 mmol) was neutralized to obtain the Na salt, which was treated with AgNO 3 . The silver salt was treated with 2,3,4,6-tetra-O-acetyl-D-glucopyranosyl bromide in dry benzene solution to obtain the protected glucopyranosyl derivative, which was subjected to mild hydrolysis to obtain 4a. 
15,16-Epoxy-17-hydroxy-ent-kauran-19-oic acid-methyl ester (7):
This compound was obtained as described by Aparicio et al. [4d] . Ent-kaurenic acid methyl ester (100 mg, 0.32 mmol) was dissolved in 10 mL of dioxan and stirred with 46 mg of SeO 2 and 0.41 mL of 30% H 2 O 2 during 4 h at room temperature. Diethyl ether extraction yielded a crude product, which was submitted to flash chromatography to yield 65 mg of 7, which crystallized from MeOH. MP 114-116 o C; [M
